InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

Current share price for PIQ : $0.200 0.04 (25%)+

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$33 PromarkerD predicts risk of DKD in Aboriginal Australians 15 Dec 2025 8:21AM $0.490 $0.200 fallen by 59.18%
$33 Investor presentation - TSN ASX Gems Conference 12 Dec 2025 9:59AM $0.460 $0.200 fallen by 56.52%
$33 Response to ASX Price Query 2 Dec 2025 3:52PM $0.470 $0.200 fallen by 57.45%
$33 US Medicare sets reimbursement price for PromarkerD DKD test 26 Nov 2025 9:58AM $0.335 $0.200 fallen by 40.30%
$33 Application for quotation of securities - PIQ 26 Nov 2025 9:29AM $0.335 $0.200 fallen by 40.30%
$33 Notification regarding unquoted securities - PIQ 26 Nov 2025 9:27AM $0.335 $0.200 fallen by 40.30%
$33 Change of Director's Interest Notice x3 26 Nov 2025 8:32AM $0.335 $0.200 fallen by 40.30%
$33 Notification of cessation of securities - PIQ 26 Nov 2025 8:29AM $0.335 $0.200 fallen by 40.30%
$33 OxiDx test correlates with superior racehorse performance 24 Nov 2025 8:37AM $0.325 $0.200 fallen by 38.46%
$33 Results of Meeting 21 Nov 2025 2:46PM $0.320 $0.200 fallen by 37.50%
$33 AGM Chair's Address and Company Presentation 21 Nov 2025 11:51AM $0.325 $0.200 fallen by 38.46%
$33 Investor presentation - Bell Potter Healthcare Conference 18 Nov 2025 10:55AM $0.340 $0.200 fallen by 41.18%
$33 Proteomics International receives $2.2m in R&D tax incentive 12 Nov 2025 9:04AM $0.345 $0.200 fallen by 42.03%
$33 PromarkerEndo test for endometriosis receives $0.5m grant 6 Nov 2025 1:51PM $0.330 $0.200 fallen by 39.39%
$33 Quarterly Activities/Appendix 4C Cash Flow Report 27 Oct 2025 9:50AM $0.350 $0.200 fallen by 42.86%
$33 Notice of Annual General Meeting/Proxy Form 22 Oct 2025 2:21PM $0.350 $0.200 fallen by 42.86%
$33 Initial Directors Interest Notice 15 Oct 2025 11:00AM $0.400 $0.200 fallen by 50%
$33 Collaboration expanded to advance Endometriosis blood test 15 Oct 2025 8:33AM $0.390 $0.200 fallen by 48.72%
$33 Appointment of Director 14 Oct 2025 9:02AM $0.365 $0.200 fallen by 45.21%
$33 Notification regarding unquoted securities - PIQ 13 Oct 2025 11:51AM $0.360 $0.200 fallen by 44.44%
$33 Proposed issue of securities - PIQ 10 Oct 2025 8:24AM $0.375 $0.200 fallen by 46.67%
$33 Appointment of Company Secretary 7 Oct 2025 8:31AM $0.390 $0.200 fallen by 48.72%
$33 Notification of cessation of securities - PIQ 1 Oct 2025 10:59AM $0.350 $0.200 fallen by 42.86%
$33 Notification regarding unquoted securities - PIQ 1 Oct 2025 10:58AM $0.350 $0.200 fallen by 42.86%
$33 Esophageal cancer test results presented at World Congress 19 Sep 2025 8:38AM $0.335 $0.200 fallen by 40.30%

26 - 50 of 683 results

Page 2 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.